Percik R - Search Results

1

Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center database.

Percik R, Liel Y, Urban D, Bar J, Ben-Ami E, Abu Tailakh M. Percik R, et al. Acta Oncol. 2021 Nov;60(11):1466-1471. doi: 10.1080/0284186X.2021.1958006. Epub 2021 Aug 11. Acta Oncol. 2021. PMID: 34379562

2

Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study.

Bar J, Markel G, Gottfried T, Percik R, Leibowitz-Amit R, Berger R, Golan T, Daher S, Taliansky A, Dudnik E, Shulman K, Urban D, Onn A. Bar J, et al. Among authors: percik r. Eur J Cancer. 2019 Oct;120:122-131. doi: 10.1016/j.ejca.2019.06.021. Epub 2019 Sep 10. Eur J Cancer. 2019. PMID: 31518968 Clinical Trial.

3

Capillary-leak syndrome: an unrecognized early immune adverse effect of checkpoint-inhibitors treatment.

Percik R, Nethanel A, Liel Y. Percik R, et al. Immunotherapy. 2021 Jun;13(8):653-659. doi: 10.2217/imt-2020-0332. Epub 2021 Apr 13. Immunotherapy. 2021. PMID: 33847145

4

Skin exposure to UVB light induces a skin-brain-gonad axis and sexual behavior.

Parikh R, Sorek E, Parikh S, Michael K, Bikovski L, Tshori S, Shefer G, Mingelgreen S, Zornitzki T, Knobler H, Chodick G, Mardamshina M, Boonman A, Kronfeld-Schor N, Bar-Joseph H, Ben-Yosef D, Amir H, Pavlovsky M, Matz H, Ben-Dov T, Golan T, Nizri E, Liber D, Liel Y, Brenner R, Gepner Y, Karnieli-Miller O, Hemi R, Shalgi R, Kimchi T, Percik R, Weller A, Levy C. Parikh R, et al. Among authors: percik r. Cell Rep. 2021 Aug 24;36(8):109579. doi: 10.1016/j.celrep.2021.109579. Cell Rep. 2021. PMID: 34433056 Free PMC article.

5

Isolated autoimmune adrenocorticotropic hormone deficiency: A positive predictor of survival among cancer patients treated with checkpoint inhibitors.

Aviv-Shimoni S, Uri I, Milloh-Raz H, Percik R. Aviv-Shimoni S, et al. Among authors: percik r. Autoimmun Rev. 2023 Sep;22(9):103387. doi: 10.1016/j.autrev.2023.103387. Epub 2023 Jun 21. Autoimmun Rev. 2023. PMID: 37352903 Review.

6

Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide.

Aharon-Hananel G, Percik R, Badarna M, Uri I, Tirosh A. Aharon-Hananel G, et al. Among authors: percik r. Endocrine. 2019 Aug;65(2):393-398. doi: 10.1007/s12020-019-01996-9. Epub 2019 Jul 2. Endocrine. 2019. PMID: 31267325

7

[No title available]

[No authors listed] [No authors listed] PMID: 32686470

8

Low risk for all-cause mortality among patients with lung neuroendocrine tumors co-diagnosed with pituitary adenomas.

Peltz-Sinvani N, Percik R, Uri I, Kfir SK, Tirosh A, Tirosh A. Peltz-Sinvani N, et al. Among authors: percik r. Endocrine. 2021 Sep;73(3):745-751. doi: 10.1007/s12020-021-02740-y. Epub 2021 May 12. Endocrine. 2021. PMID: 33982234

9

Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis.

Percik R, Larkin J, Morganstein DL. Percik R, et al. Lancet Oncol. 2021 Jul;22(7):905-907. doi: 10.1016/S1470-2045(21)00305-3. Lancet Oncol. 2021. PMID: 34197741 No abstract available.

10

Cardiorespiratory fitness and survival following cancer diagnosis.

Fardman A, Banschick GD, Rabia R, Percik R, Fourey D, Segev S, Klempfner R, Grossman E, Maor E. Fardman A, et al. Among authors: percik r. Eur J Prev Cardiol. 2021 Sep 20;28(11):1242-1249. doi: 10.1177/2047487320930873. Epub 2020 Jul 19. Eur J Prev Cardiol. 2021. PMID: 34551084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters